-
Signature
-
/s/ Jon Ayotte, as attorney-in-fact for David Brainard
-
Issuer symbol
-
EVER
-
Transactions as of
-
26 Dec 2024
-
Net transactions value
-
-$342,845
-
Form type
-
4
-
Filing time
-
30 Dec 2024, 17:00:03 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
EVER |
Class A Common Stock |
Options Exercise |
$132,323 |
+14,062 |
+12% |
$9.41 |
130,274 |
26 Dec 2024 |
Direct |
F1 |
| transaction |
EVER |
Class A Common Stock |
Options Exercise |
$107,745 |
+15,186 |
+12% |
$7.10 |
145,460 |
26 Dec 2024 |
Direct |
F1 |
| transaction |
EVER |
Class A Common Stock |
Sale |
$582,913 |
-29,248 |
-20% |
$19.93 |
116,212 |
26 Dec 2024 |
Direct |
F1, F2 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
EVER |
Stock Option (right to buy) |
Options Exercise |
$0 |
-14,062 |
-60% |
$0.000000 |
9,375 |
26 Dec 2024 |
Class A Common Stock |
14,062 |
$9.41 |
Direct |
F1, F3 |
| transaction |
EVER |
Stock Option (right to buy) |
Options Exercise |
$0 |
-2,500 |
-27% |
$0.000000 |
6,875 |
26 Dec 2024 |
Class A Common Stock |
2,500 |
$7.10 |
Direct |
F1, F4 |
| transaction |
EVER |
Stock Option (right to buy) |
Options Exercise |
$0 |
-12,686 |
-57% |
$0.000000 |
9,515 |
26 Dec 2024 |
Class A Common Stock |
12,686 |
$7.10 |
Direct |
F1, F5 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: